BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 29724819)

  • 1. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
    Zhu S; Chen J; Diamond SL
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.
    Muthard RW; Welsh JD; Brass LF; Diamond SL
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):645-54. PubMed ID: 25614284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced model to predict thrombin and fibrin during thrombosis on collagen/tissue factor under venous flow: Roles of γ'-fibrin and factor XIa.
    Chen J; Diamond SL
    PLoS Comput Biol; 2019 Aug; 15(8):e1007266. PubMed ID: 31381558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin.
    Colace TV; Muthard RW; Diamond SL
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1466-76. PubMed ID: 22516070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces.
    Zhu S; Lu Y; Sinno T; Diamond SL
    J Biol Chem; 2016 Oct; 291(44):23027-23035. PubMed ID: 27605669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating thrombin-loaded fibrin in whole blood clot microfluidic assay via fluorogenic peptide.
    Crossen J; Shankar KN; Diamond SL
    Biophys J; 2023 Feb; 122(4):697-712. PubMed ID: 36635963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport physics and biorheology in the setting of hemostasis and thrombosis.
    Brass LF; Diamond SL
    J Thromb Haemost; 2016 May; 14(5):906-17. PubMed ID: 26848552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
    Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Tissue Factor Localization on Blood Clot Structure and Resistance under Venous Shear.
    Govindarajan V; Zhu S; Li R; Lu Y; Diamond SL; Reifman J; Mitrophanov AY
    Biophys J; 2018 Feb; 114(4):978-991. PubMed ID: 29490257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathrombus Fibrin Attenuates Spatial Sorting of Phosphatidylserine Exposing Platelets during Clotting Under Flow.
    Trigani KT; Diamond SL
    Thromb Haemost; 2021 Jan; 121(1):46-57. PubMed ID: 32961573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse.
    Welsh JD; Colace TV; Muthard RW; Stalker TJ; Brass LF; Diamond SL
    J Thromb Haemost; 2012 Nov; 10(11):2344-53. PubMed ID: 22978514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow.
    Zhu S; Travers RJ; Morrissey JH; Diamond SL
    Blood; 2015 Sep; 126(12):1494-502. PubMed ID: 26136249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
    Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
    Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure.
    Cantero M; Rojas H; Anglés-Cano E; Marchi R
    BMC Mol Cell Biol; 2019 Nov; 20(1):47. PubMed ID: 31675913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidic and computational study of structural properties and resistance to flow of blood clots under arterial shear.
    Mitrophanov AY; Govindarajan V; Zhu S; Li R; Lu Y; Diamond SL; Reifman J
    Biomech Model Mechanobiol; 2019 Oct; 18(5):1461-1474. PubMed ID: 31055691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.
    Haynes LM; Orfeo T; Mann KG; Everse SJ; Brummel-Ziedins KE
    Biophys J; 2017 Apr; 112(8):1634-1644. PubMed ID: 28445754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow and delta-P dictate where thrombin, fibrin, and von Willebrand Factor will be found.
    Diamond SL
    Thromb Res; 2016 May; 141 Suppl 2():S22-4. PubMed ID: 27207416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.